Navigation Links
DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
Date:1/25/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Jan. 25, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: BRRY) ("DelMar") today announced the successful acquisition (the "Acquisition"), through a share exchange agreement, of all of the outstanding shares of Del Mar Pharmaceuticals (BC) Ltd., a clinical and commercial stage drug development company with a focus on the treatment of cancer.  Concurrent with the Acquisition, DelMar completed the first closing in a private placement consisting of approximately 6.7 million units of its securities to qualified accredited investors, for total gross proceeds of approximately $5.4 million.

DelMar will be quoted on the OTC QB under the symbol "BRRY" beginning January 25th, 2013; the symbol will be changed to "DMPI" on or about January 31, 2013.

Charles Vista LLC acted as the company's placement agent in the unit offering. Each unit consists of one share of common stock and one common stock purchase warrant.

"DelMar is pleased to achieve this important milestone," stated Jeffrey Bacha , Chief Executive Officer of DelMar. "Becoming a publicly traded company will allow for broad and diversified investor exposure and access to the capital markets.  These funds will position us to expand and accelerate our drug development activities with our lead drug candidate, VAL-083.  Our company and our management are committed to creating shareholder value by executing on our mission to rapidly develop and commercialize proven cancer therapies in new orphan drug indications in areas of significant unmet medical need, particularly where patients have failed modern targeted medicines."

VAL-083, represents a "first in class" small-molecule chemotherapeutic, which means that the molecular structure of VAL-083 is not an analogue or derivative of other small molecule chemotherapeutics approved for
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
3. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
4. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
5. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
6. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
7. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
8. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
9. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... largest solar boat, today announced a new speed record ... Having left from Las Palmas, Spain, on April 25, ... across the Atlantic Ocean at the average speed of ... French West Indies on May 18, 2013. The first-of-its-kind ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), ... proudly announced that the company's YouTube channel on ... views on YouTube. The company uses YouTube as a ... and training for small businesses with much success. , ... tips helpful for their SEO strategies", explained Jason McDonald, ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Topricin ... BioMedics, Inc., has been listed among nationally recommended ... an initiative conducted by "U.S. News" Health in ... earned the “No. 1 Pharmacists Recommended designation” ... other national OTC brands, and is the only ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...
Breaking Biology Technology:MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... to Six Months of Pain Relief ... in OA Knee Pain, CAMBRIDGE, ... has been granted European approval,through a CE mark for Synvisc-One(TM), the single treatment ... provide up to,six months of proven pain relief from osteoarthritis (OA) of the ...
... Calif., Dec. 19 AMDL, Inc., (Amex:,ADL), today ... manufacturer, and marketer of pharmaceutical, nutraceutical,diagnostic, consumer healthcare ... first large-scale JPGreen Health and Personal Care Center ... Jade to be converted,into a flagship JPGreen Health ...
... is also available in German . , ... range can be measured with a resolution of less than ... made their use in practice more difficult, could now be ... correlation of singly interfering X-ray photons. , X-ray interferometers can ...
Cached Biology Technology:Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM) 2Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM) 3Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM) 4Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM) 5AMDL's First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China 2Faster X-ray interferometers due to single-photon interference 2
(Date:5/16/2013)... Illustrating a commitment to the support of underrepresented ... Research Foundation has announced the inaugural AGA Investing ... Supported by the National Institute of Diabetes and ... helps underrepresented minority students to further their research ... "By establishing this new award, AGA demonstrates its ...
(Date:5/16/2013)... living closer to a fast food restaurant had a ... further away from fast food, according to researchers at ... this association was particularly strong among those with a ... in the American Journal of Public Health ... fast food restaurant, and among lower-income African-Americans, the density, ...
(Date:5/16/2013)... MA -- Injectable nanoparticles developed at MIT may ... 1 diabetes to constantly monitor their blood-sugar levels ... were designed to sense glucose levels in the ... of insulin, thereby replacing the function of pancreatic ... Type 1 diabetes. Ultimately, this type of system ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
... Revolution, over half of all the CO2 produced by burning ... drop faster than any time in the last 650,000 years ... this causes fish to lose their sense of smell, but ... shows that fish hearing is also compromised. Working with ...
... forests of western North America, these insects may kill ... rise in overall temperatures over the past several years ... in an epidemic and possibly making this mountain pine ... North America. Dr. Francois Teste and colleagues from ...
... occurs constantly. But the dialogue is rather extraordinary. The orators ... tissues. And for biologists, the fundamental question remains as to ... and organs. One avenue of research receiving support ... a field that promotes the study of the cell as ...
Cached Biology News:Ocean acidification leaves clownfish deaf to predators 2Storing seeds for a rainy day -- or in this case, a fire 2Cells do talk to one another, but the question remains how 2Cells do talk to one another, but the question remains how 3
Request Info...
supplied with 10x reaction buffer...
... fragment is a proteolytic product ... DNA Polymerase I which retains ... exonuclease activity, but has lost ... retains the polymerization fidelity of ...
Mouse monoclonal [HL-37] to HLA DQ1 + HLA DQ3 ( Abpromise for all tested applications)....
Biology Products: